Raze Therapeutics

If things continue working as they have to this point, Stealth BioTherapeutics may launch a pivotal trial in 2016 that could obtain approval for one drug in roughly 270 very rare diseases, all of wh

Start-Up Execs Cristal Therapeutics Jeroen Tonnaer, PhD To: CBO (April) From: Merck & Co. Inc. Phone: +31 433 88 58 68 Editas Medicine Inc. Vic Myer, PhD To: CTO (April) From: Exec. Dir.

New At The Helm Company Changes AVNI , Yuval, MD To: Beta-O2 Technologies Ltd. , CEO (March) From: Giza VC, Partner Phone: +972 3 918 0700 BECKMAN , Richard, MD To: Unilife Corp. , SVP, CM

Start-Up Execs Allena Pharmaceuticals Inc. Louis Brenner, MD To: COO (April) From: SVP, CMO, Idera Pharmaceuticals Phone: 215-791-0105 Aimmune Therapeutics Inc. Mary Rozenman, PhD To: SVP,